Private Capital Management »

Transcode Therapeutics shares owned by Private Capital Management

Quarter-by-quarter ownership of Transcode Therapeutics (RNAZ) shares owned by Private Capital Management from 13F filings

Historical chart of Private Capital Management investment in Transcode Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Transcode Therapeutics held by Private Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Transcode Therapeutics by Private Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $18k 18k 1.01

More positions owned by Private Capital Management

Dimensional Etf Trust Us Equity Etf (DFUS)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Invesco Exchange Traded Fd T S&p500 Quality (SPHQ)
Vanguard Index Fds Value Etf (VTV)
Vanguard Scottsdale Fds Vng Rus1000idx (VONE)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
Vanguard Index Fds Small Cp Etf (VB)
J P Morgan Exchange Traded F Hedged Equity La (HELO)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Dimensional Etf Trust Emgr Cre Eqt Mng (DFAE)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p Scp Etf (IJR)
Microsoft Corporation (MSFT)
Pepsi (PEP)

View all positions for Private Capital Management

Top funds holding Transcode Therapeutics

Geode Capital Management
Sheets Smith Wealth Management
Jane Street
Virtu Financial
Private Capital Management
Captrust Financial Advisors
Two Sigma Securities
Morgan Stanley
Tower Research Capital
Bank of America Corporation

View all funds holding Transcode Therapeutics